Virtus LifeSci Biotech Products ETF
11 hedge funds and large institutions have $4.47M invested in Virtus LifeSci Biotech Products ETF in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$383K | |
| 2 | +$10K | |
| 3 | +$5K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.31K |
Top Sellers
| 1 | -$1.54M | |
| 2 | -$429K | |
| 3 | -$283K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$119K |
| 5 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$5.22K |